Journey Strategic Wealth LLC Grows Position in Relx Plc (NYSE:RELX)

Journey Strategic Wealth LLC raised its position in shares of Relx Plc (NYSE:RELXFree Report) by 54.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,814 shares of the technology company’s stock after acquiring an additional 3,117 shares during the period. Journey Strategic Wealth LLC’s holdings in Relx were worth $400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Marshall Wace LLP bought a new stake in Relx during the second quarter worth approximately $312,000. AQR Capital Management LLC bought a new position in shares of Relx during the 2nd quarter valued at approximately $433,000. NewEdge Advisors LLC raised its holdings in Relx by 143.5% during the 2nd quarter. NewEdge Advisors LLC now owns 30,223 shares of the technology company’s stock valued at $1,387,000 after buying an additional 17,809 shares during the period. Cetera Investment Advisers lifted its position in Relx by 0.6% in the second quarter. Cetera Investment Advisers now owns 61,005 shares of the technology company’s stock worth $2,799,000 after buying an additional 339 shares during the last quarter. Finally, Sanctuary Advisors LLC purchased a new position in Relx during the second quarter worth $5,016,000. 15.02% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

RELX has been the topic of several recent analyst reports. StockNews.com began coverage on shares of Relx in a research note on Wednesday, October 30th. They issued a “hold” rating on the stock. Redburn Atlantic started coverage on shares of Relx in a research note on Wednesday, January 8th. They issued a “buy” rating for the company.

Get Our Latest Stock Report on Relx

Relx Stock Performance

RELX stock opened at $49.87 on Monday. Relx Plc has a 12 month low of $40.25 and a 12 month high of $50.55. The firm’s 50-day moving average is $47.13 and its 200 day moving average is $46.81. The company has a quick ratio of 0.42, a current ratio of 0.48 and a debt-to-equity ratio of 1.63.

About Relx

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

See Also

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.